Latest Patents News

Neometals has reported a maiden Mineral Resource Estimate for its Ironclad gold deposit at Barrambie and signed a non-binding MoU with Rio Tinto to advance its lithium processing technology, alongside progress in battery recycling plant commissioning.

AML3D has appointed Arc Additive as its UK and European distribution partner, marking a strategic push into key manufacturing and defence markets across Europe. This move follows a successful capital raise and a contract with BAE Systems UK, underpinning AML3D’s growth ambitions.

Latrobe Magnesium Limited has extended its Pilot Project Licence with EPA Victoria until February 2027, paving the way to resume magnesium oxide production at its Hazelwood North site in August 2025.

ClearVue Technologies has appointed Douglas Hunt as its permanent Global CEO, unveiling a refreshed leadership team focused on scaling sales, manufacturing, and product innovation. The new executives have agreed to sub-market pay until the share price hits 35 cents, signaling strong alignment with shareholder interests.

Proteomics International Laboratories has secured $12 million to fast-track its precision diagnostic tests, including the US launch of PromarkerD for diabetic kidney disease, backed by a new AMA billing code. The company also advances its pipeline with new patents and commercial partnerships.

Volt Group Limited (ASX – VPR) has initiated an on-market share buy-back of up to 5% of its issued capital, aligning with its capital management strategy as it advances commercialisation of its innovative zero-emission technologies.

Viridis Mining and Minerals has been selected by Brazil's BNDES and FINEP to receive significant funding under a US$903 million strategic minerals initiative, accelerating its Colossus rare earths project and downstream operations.

Advanced Health Intelligence Ltd (AHI) reports robust commercial progress and strategic funding moves in Q1 2025 despite ongoing ASX trading suspension and recent NASDAQ delisting. Key partnerships and technology validations position the company for a strong global scale-up.

Titomic Limited has successfully raised A$50 million through a strategic share placement, aiming to fuel its growth in industrial-scale metal additive manufacturing. The capital raise underscores investor confidence as the company prepares to expand its global footprint.

Universal Biosensors reports a $1.59 million improvement in operating cash outflows for Q2 2025, maintaining $2.55 million in cash as it advances commercialization across blood, wine, and water testing markets.

Novonix Limited reports significant progress in its synthetic graphite anode materials production, benefiting from new US tariffs on Chinese imports and strategic leadership appointments. The company also secures up to US$100 million in convertible debenture funding to support expansion plans.

Metal Powder Works has significantly expanded its production capacity and customer base in the June 2025 quarter, while securing strategic partnerships that position it strongly in defence and nuclear sectors.